Nuzenio

Loqtorzi

Loqtorzi news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: - GuruFocusGuruFocus · Thu, 06 Aug 2026 06:22:30 GMT Coherus Oncology Q2 2026 Results: LOQTORZI Revenue Growth, Pipeline Progress, and Financial Update - MinichartMinichart · Thu, 06 Aug 2026 01:40:00 GMT CHRS: LOQTORZI sales rose 15% in Q2, with key clinical data readouts expected later in 2026 - TradingViewTradingView · Wed, 05 Aug 2026 23:23:51 GMT Coherus Oncology Q2 2026 Earnings: LOQTORZI Growth Narrows the Loss - TradingKeyTradingKey · Wed, 05 Aug 2026 22:23:15 GMT Coherus Oncology (NASDAQ: CHRS) posts Q2 2026 loss amid growing LOQTORZI revenue - Stock TitanStock Titan · Wed, 05 Aug 2026 21:14:57 GMT Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates - TradingViewTradingView · Wed, 05 Aug 2026 20:50:33 GMT Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:28:19 GMT Press Release: Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update - MoomooMoomoo · Wed, 05 Aug 2026 20:28:00 GMT

Timeline

Thu, 06 Aug 2026 06:22:30 GMTCoherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: - GuruFocus

Thu, 06 Aug 2026 01:40:00 GMTCoherus Oncology Q2 2026 Results: LOQTORZI Revenue Growth, Pipeline Progress, and Financial Update - Minichart

Wed, 05 Aug 2026 23:23:51 GMTCHRS: LOQTORZI sales rose 15% in Q2, with key clinical data readouts expected later in 2026 - TradingView

Wed, 05 Aug 2026 22:23:15 GMTCoherus Oncology Q2 2026 Earnings: LOQTORZI Growth Narrows the Loss - TradingKey

Wed, 05 Aug 2026 21:14:57 GMTCoherus Oncology (NASDAQ: CHRS) posts Q2 2026 loss amid growing LOQTORZI revenue - Stock Titan

Wed, 05 Aug 2026 20:50:33 GMTCoherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

CHRS7 live mentions Coherus Oncology5 live mentions NASDAQ4 live mentions Financial Results4 live mentions Provides Business Update4 live mentions Coherus Oncology Reports3 live mentions Second Quarter3 live mentions Earnings Call Highlights2 live mentions Results2 live mentions LOQTORZI Revenue Growth2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Loqtorzi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.